Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 223,171Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 55GLAXO GRP LTD

02 55GLAXOSMITHKLINE

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

filter clear-filterReset all filters

PharmaCompass

01

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

US Patent Number : 8511304

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204275

Patent Use Code : U-1691

Delist Requested :

Patent Use Description : INDICATED FOR THE ONCE...

Patent Expiration Date : 2027-06-14

blank

02

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE

US Patent Number : 8309572

Drug Substance Claim :

Drug Product Claim :

Application Number : 209482

Patent Use Code : U-2129

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-04-27

blank

03

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

US Patent Number : 7439393

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204275

Patent Use Code : U-2099

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-05-21

blank

04

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

US Patent Number : 8511304

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204275

Patent Use Code : U-1424

Delist Requested :

Patent Use Description : LONG-TERM, ONCE DAILY ...

Patent Expiration Date : 2027-06-14

blank

05

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE

US Patent Number : 8309572

Drug Substance Claim :

Drug Product Claim :

Application Number : 203975

Patent Use Code : U-1476

Delist Requested :

Patent Use Description : INDICATED FOR THE LONG...

Patent Expiration Date : 2025-04-27

blank

06

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

US Patent Number : 7439393

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204275

Patent Use Code : U-1691

Delist Requested :

Patent Use Description : INDICATED FOR THE ONCE...

Patent Expiration Date : 2025-05-21

blank

07

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

US Patent Number : 7439393

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204275

Patent Use Code : U-2100

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-05-21

blank

08

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

US Patent Number : 7439393

Drug Substance Claim : Y

Drug Product Claim : Y

Application Number : 204275

Patent Use Code : U-2100

Delist Requested :

Patent Use Description :

Patent Expiration Date : 2025-05-21

blank

09

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE

US Patent Number : 8183257

Drug Substance Claim :

Drug Product Claim :

Application Number : 203975

Patent Use Code : U-1476

Delist Requested :

Patent Use Description : INDICATED FOR THE LONG...

Patent Expiration Date : 2025-07-27

blank

10

arrow
Medlab Asia & Asia Health
Not Confirmed
arrow
Medlab Asia & Asia Health
Not Confirmed

FLUTICASONE FUROATE; VILANTEROL TRIFENATATE

US Patent Number : 11116721

Drug Substance Claim :

Drug Product Claim : Y

Application Number : 204275

Patent Use Code : U-1401

Delist Requested :

Patent Use Description : INDICATED FOR LONG-TER...

Patent Expiration Date : 2029-02-26

blank